• Home
  • NEW DAY MEDICINE
  • 5 (79) 2025
  • 165 -5 (79) 2025 - Mavlonov N.H. - RISK FACTORS AFFECTING THE OCCURRENCE AND PROGRESS OF THE DISEASE IN PATIENTS WITH UNSTABLE ANGINA CARDIAC

165 -5 (79) 2025 - Mavlonov N.H. - RISK FACTORS AFFECTING THE OCCURRENCE AND PROGRESS OF THE DISEASE IN PATIENTS WITH UNSTABLE ANGINA CARDIAC

RISK FACTORS AFFECTING THE OCCURRENCE AND PROGRESS OF THE DISEASE IN PATIENTS WITH UNSTABLE ANGINA CARDIAC

Mavlonov N.H. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Cardiovascular diseases are among the most common causes of death in developed and developing countries. Among them, the share of unstable angina is also high. Its course and progression are significantly influenced by the risk factors present in a person, and their study and prevention are among the urgent issues of modern preventive medicine.

Keywords: ischemic heart disease, acute coronary syndrome, angina, unstable angina, myocardial infarction.

First page

821

Last page

826

For citation:Mavlonov N.H. - RISK FACTORS AFFECTING THE OCCURRENCE AND PROGRESS OF THE DISEASE IN PATIENTS WITH UNSTABLE ANGINA CARDIAC//New Day in Medicine 5(79)2025 821-826 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

  1. Alkhawam H, Madanieh R, Fabisevich M, Sogomonian R, El-Hunjul M, Madanieh A, Lieber JJ, Vittorio TJ. The role of alcohol abuse and tobacco use in the incidence of early acute coronary syndrome. Circulation. 2015;132:A14365.
  2. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am CollCardiol. 2004;43(10):1731–7.
  3. Andreenko E.Yu., Yavelov I.S., Lukyanov M.M., et al. ischemic heart disease in young people: prevalence and cardiovascular risk factors. Cardiology. 2018;58 (10):53-8. (In Russ.).
  4. Barth J, Jacob T, Daha I, Critchley JA. Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database Syst Rev 2015;7: CD006886. https://doi.org/10.1002/14651858.CD006886.pub2 449.
  5. Celik T, Iyisoy A. Premature coronary artery disease in young patients: An uncommon but growing entity. Int J Cardiol. 2010;144 (1):131-2. doi:10.1016/j. ijcard.2008.12.150.
  6. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004:CD003041. https://doi.org/10.1002/ 14651858.CD003041.pub2.
  7. DeFilippis EM, Bajaj NS, Singh A, Malloy R, Givertz MM, Blankstein R, et al. Marijuana use in patients with cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol 2020;75:320–32. https://doi.org/10.1016/j.jacc.2019.11.025.
  8. Go AS, Mozaffarian D, Roger VL и др. Статистика заболеваний сердца и инсульта — обновление 2013 г.: отчет Американской кардиологической ассоциации. Circulation. 2013;127:e6–e245. doi: 10.1161/CIR.0b013e31828124ad.
  9. González-Pacheco H, Vargas-Barrón J, Vallejo M, Piña-Reyna Y, Altamirano-Castillo A, Sánchez-Tapia P, Martínez-Sánchez C. Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease. TherClin Risk Manag. 2014;10:815–23.
  10. Gupta R, Gupta S, Sharma S, Sinha DN, Mehrotra R. Risk of Coronary Heart Disease Among Smokeless Tobacco Users: Results of Systematic Review and Meta-Analysis of Global Data. Nicotine Tob Res. 2019;21(1):25-31. doi:10.1093/ntr/nty002.
  11. Hernández MAL. Hyperglycemia and Diabetes in Myocardial Infarction: Diabetes Mellitus- Insights and Perspectives. 2013. Chapter 10. 169–192.
  12. Huxley R.R., Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. The Lancet. 2011. 378(9799): 1297-1305. doi: 10.1016/s0140-6736(11)60781-2.
  13. Joshi P, Islam S, Pais P, et al. Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other Countries. JAMA. 2007;297(3):286–294. doi:10.1001/jama.297.3.286.
  14. Kavousi M, Pisinger C, Barthelemy JC, De Smedt D, Koskinas K, Marques-Vidal P, et al. Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2020;28:1552–66. https://doi.org/10.1177/2047487320941993.
  15. Lv X, Sun J, Bi Y, et al. Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and metaanalysis. Int J Cardiol. 2015;199:106-115. doi:10.1016/j.ijcard.2015.07.011.
  16. Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014 Mar 15;383(9921):999-1008. doi: 10.1016/S0140-6736(13)61752-3. Epub 2013 Sep 29. PMID: 24084292; PMCID: PMC4159698.
  17. Medagama A, Bandara R, De Silva C, Galgomuwa MP. Management of acute coronary syndromes in a developing country; time for a paradigm shift?an observational study. BMC Cardiovasc Disord. 2015;15:133. https://doi.org/10.1186/s12872-015-0125-y.
  18. Mohanan PP, Mathew R, Harikrishnan S, Krishnan MN, Zachariah G, Joseph J, et al. Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS registry. Eur Heart J. 2013;34(2):121–9.
  19. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998;316(7137):1043-1047. doi:10.1136/bmj.316.7137.1043.
  20. Prochaska JJ, Benowitz NL. The past, present, and future of nicotine addiction therapy. Annu Rev Med 2016;67:467–86. https://doi.org/10.1146/annurev-med-111314-033712.

    file

    download